Vistagen Therapeutics, Inc. (VTGN) stock
VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3076% below fair value
$0.20+0.01 (+6.12%)
Close on Nov 18, 2026Market cap $8.85MP/E –Yield –
Vistagen Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vistagen Therapeutics's market cap was $7.67M on Nov 11, 2026, against $159.19M a year earlier. Over the last 5 years it ranged from $6.87M to $297.50M, with a median of $53.45M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.67M | -64.3% |
| 2025 | Dec 31, 2025 | $21.50M | -75.9% |
| 2024 | Dec 31, 2024 | $89.34M | +121.2% |
| 2023 | Dec 29, 2023 | $40.40M | +96.5% |
| 2022 | Dec 30, 2022 | $20.56M | -93.1% |
| 2021 | Dec 31, 2021 | $297.50M | +194.0% |
| 2020 | Dec 31, 2020 | $101.21M | +288.5% |
| 2019 | Dec 31, 2019 | $26.05M | -18.8% |
| 2018 | Dec 31, 2018 | $32.10M | +222.1% |
| 2017 | Dec 29, 2017 | $9.97M | +51.1% |
| 2016 | Dec 30, 2016 | $6.60M | -49.2% |
| 2015 | Dec 31, 2015 | $12.98M | +38.9% |
| 2014 | Dec 31, 2014 | $9.34M | +8.1% |
| 2013 | Dec 31, 2013 | $8.64M | -28.8% |
| 2012 | Dec 31, 2012 | $12.14M | -73.9% |
| 2011 | Dec 30, 2011 | $46.49M | – |
See a number that looks wrong?